Concepedia

Steve D. Thomas

SD

Statistics

Publications

23

Citations

1.7K

H-Index

20

Active since

1987

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Argus International (United States)

Birmingham VA Medical Center

Battelle

University of Alabama at Birmingham

Steve D. Thomas is an author at Bristol-Myers Squibb (Switzerland) specializing in pharmacology, pharmacy, and toxicology.

Publications per year

1987–2004

23

Publications

23

A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague–Dawley rats

Steve Teo, David Stirling, Steve D. Thomas et al. · Toxicology · 2002 · 347 citations

, , +10

Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

Scott W. Blume, Richard C. Snyder, Ratna B. Ray et al. · Journal of Clinical Investigation · 1991 · 332 citations · Full text

, , +13

S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide

Jerome B. Zeldis, Bruce A. Williams, Steve D. Thomas et al. · Clinical Therapeutics · 1999 · 223 citations

, , +1

Thalidomide for the Treatment of AIDS-Associated Wasting

Gilla Kaplan, Steve D. Thomas, Daniel S. Fierer et al. · AIDS Research and Human Retroviruses · 2000 · 92 citations

, , +9

Rapid Communication: Mithramycin Selectively Inhibits Transcription Of G-C Containing DNA

Donald M. Miller, Steve D. Thomas, Ratna B. Ray et al. · The American Journal of the Medical Sciences · 1987 · 85 citations

, , +7

1–5 of 23